ASPN/PAS
Program
Schedule
(as of
December 31, 2001) |
Saturday,
May 4, 2002
8:00am – 11:00am
ASPN Council Meeting
10:00am
– 12:00pm
PAS
Educational Seminars
11:00am – 12:30pm
ASPN Committee Luncheons
1:00pm – 3:00pm
ASPN Symposium:
Vasculitis and Renal Disease in Children
Chair: Sharon P. Andreoli, Indiana University,
Indianapolis, IN and Allison Eddy, University of
Washington, Seattle, WA
Diagnosis
of Vasculitic Renal Disease in Children
Thomas J.A. Lehman,
Cornell Medical Center, New York, NY
ANCA Associated Renal Disease in Children
Debbie Gipson,
University of North Carolina, Chapel Hill, NC
Transition of Acute Glomerulonephritis to End Stage
Renal Disease
Allison Eddy,
University of Washington, Seattle, WA
Management and Therapy of Lupus Nephritis
James E. Balow,
NIDDK, National Institutes of Health, Bethesda, MD
1:00pm
– 3:00pm
PAS
Educational Seminars
3:15pm – 5:15pm
Nephrology
Platform I
PAS/ASPN Original Science Abstracts
(Abstract session
information will be posted in mid-February)
5:15pm – 7:15pm
Poster
Session I, PAS Opening Reception & Exhibits
Nephrology Poster I
PAS/ASPN Original Science Abstracts
(Abstract session
information will be posted in mid-February)
8:00pm – 10:00pm
ASPN Resident/Trainee Reception
Sunday,
May 5, 2002
7:00am – 8:30am
ASPN Breakfast Business Meeting
9:00am –11:00am
ASPN Symposium:
Molecular Determinants and Clinical Implications of Renal
Tubular (Dys)Function
Chairs: William Schnaper, Northwestern University,
Chicago, IL and Aaron Friedman, University of Wisconsin,
Madison, WI
Nephrogenic Diabetes Insipidus: From the
Ship Hopewell to Misfolded Proteins
Daniel G. Bichet, University of
Montreal, Canada
Renal Tubular Acidosis — Moving a Step Forward
Uri Alon, University
of Missouri, Kansas, MO
Clinical, Molecular and
Therapeutic Aspects of Nephropathic Cystinosis and Its
Variants
William Gahl, NICHD,
National Institute of Health, Bethesda, MD
Renal Salt Handling: Lessons from the Clinic
Lisa Guay-Woodford,
University of Alabama At Birmingham, AL
11:45am – 1:45pm
Poster
Session II
PAS/ASPN Original Science Abstracts
(Abstract session
information will be posted in mid-February)
2:00pm – 4:00pm
PAS/ASPN/ASPHO Topic Symposium:
Cancer, Blood, and the Kidney: Common Themes
Chairs: Ellis D. Avner,
President, American Society of Pediatric Nephrology and
George R. Buchanan, President, American Society of
Pediatric Hematology/Oncology
Many children with
cancer, hematological disorders, or kidney disease have
complex, multisystem problems. Advances in cell and
molecular biology provide insights into the
interrelationships of cancer, blood, and the kidney and
have led to new diagnostic and therapeutic approaches for
the clinician. Such approaches are reviewed in this
symposium which focuses specifically on the nephrological
complications of sickle cell anemia and bone marrow
transplantation, hematological complications of nephrotic
syndrome, and the molecular pathophysiology of WT-1
associated disorders.
Sickle Cell
Nephropathy: Pathophysiology and Therapy
Jon Scheinman,
University of Kansas Medical Center, Kansas City, KS
Thromboembolic Complications of the Nephrotic Syndrome
M. Patricia
Massicotte, University of Toronto, Hospital for Sick
Children, Toronto, ON, Canada
Renal Complications of Bone Marrow Transplantation
Ruth McDonald, Univ
of Washington/Children’s Hosp & Reg Med Ctr,
Seattle, WA
Molecular Pathophysiology of Wilm's Tumor and
Denys-Drash/Frasier Syndromes
Max J. Coppes,
Alberta Children’s Hosp, Children’s Cancer
Program, Calgary, AB, Canada
Sponsored jointly with the American
Society of Pediatric Hematology/Oncology, the American
Society of Pediatric Nephrology and the Pediatric Academic
Societies
2:00pm – 4:00pm
PAS State of the Art Plenary:
Children as Research Subjects: Ethical and Regulatory
Issues
Chair: Myron Genel, Yale
University School of Medicine, New Haven, CT
A number of highly
publicized adverse events, including the death of two
volunteers participating in non-therapeutic research, and
the federal shutdown of research at many well recognized
academic institutions because of inadequate compliance
with regulatory requirements have intensified scrutiny of
the protection afforded to human subjects participating in
research, including children. Furthermore a Maryland court
has recently decreed that children cannot participate in
research without the potential for direct benefit. As a
consequence there has been increasing media attention and
Congressional concern regarding the adequacy of
institutional oversight and investigator attentiveness to
established standards and regulations. In addition, new
regulations issued under the Health Insurance Portability
and Accountability Act of l996 (HIPAA) threaten the
capacity to conduct health services and outcomes research.
These issues will be addressed in the 9th annual Public
Policy Plenary Symposium in an interactive format intended
to stimulate dialogue among the members of the panel and
with the audience.
Overseeing Research
in Children: New Concerns and New Regulations
Alan R. Fleischman,
The New York Academy of Medicine, New York, NY
International Health Research: Where Bioethics,
Politics and Economics Converge
Eric Meslin, Indiana
University School of Medicine, Indianapolis, IN
Compliance: What You and Your Institution Need To Know
(and Do)
Patricia Pearl O’Rourke,
Partners HealthCare Systems, Inc., Boston, MA
HIPAA, Privacy and
Confidentiality and Research in Children?
Sara Rosenbaum,
George Washington University, Washington, DC
Sponsored jointly with the Public Policy
Council of the APS, AMSPDC, SPR and the Public Policy
Committee of the APA
4:15pm – 6:15pm
Nephrology
Platform II
PAS/ASPN Original Science Abstracts
(Abstract session
information will be posted in mid-February)
7:30pm – 10:00pm
ASPN Social Event
Monday,
May 6, 2002
7:30am – 9:30am
ASPN Breakfast and Awards
10:00am – 12:00pm
ASPN Symposium:
Molecular Basis of Renal Development and Disease
Chairs: Ellis D. Avner, Case Western Reserve
University, Cleveland, OH and Paul R. Goodyer, McGill
University, Montreal, Canada
Renal Development: A
Molecular Overview
Christopher R.
Burrow, Mt. Sinai School of Medicine, New York, NY
Pax 2 in Renal Maldevelopment
Paul R. Goodyer,
McGill University, Montreal, Canada
Developmental Interactions of the Renin-Angiotensin
System with Cyclooxygenase-2
Victoria F. Norwood,
University of Virginia, Charlottesville, VA
Polycystin: Kidney Development and PKD
Patricia D. Wilson,
Mt. Sinai School of Medicine, New York, NY
1:00pm – 3:00pm
ASPN Symposium:
ESRD — Long Term Issues
Chairs: Frederick Kaskel, Albert
Einstein College of Medicine, Bronx, NY and Craig Wong,
Children’s Hospital of New Mexico, Albuquerque, NM
Cardiovascular Risk
Factors in ESRD
Rulan Parekh, Johns
Hopkins University, Baltimore, MD
Modifications of Cardiovascular Risk Factors
Ronald J. Portman,
University of Texas, Houston, TX
Update on Bone Disease in ESRD
Mary Beth Leonard,
The Children’s Hospital of Philadelphia, PA
Advances in Dialytic Therapies
Stuart Goldstein,
Texas Children’s Hospital, Houston, TX
|
